Loading clinical trials...
Loading clinical trials...
A Prospective Observational Study of Patients Receiving Dupilumab for Prurigo Nodularis
Conditions
Interventions
Dupilumab
Locations
49
United States
Medical Dermatology Specialists Site Number : 8400005
Phoenix, Arizona, United States
Saguaro Dermatology Associates, LLC - Probity - PPDS- Site Number : 8400024
Phoenix, Arizona, United States
Center for Dermatology Clinical Research- Site Number : 8400002
Fremont, California, United States
Halcyon Dermatology- Site Number : 8400023
Laguna Hills, California, United States
Mission Dermatology - Rancho Santa Margarita- Site Number : 8400015
Rancho Santa Margarita, California, United States
Golden State Dermatology- Site Number : 8400014
Walnut Creek, California, United States
Start Date
December 12, 2023
Primary Completion Date
September 22, 2026
Completion Date
September 22, 2026
Last Updated
September 16, 2025
NCT06516952
NCT06342713
NCT06779136
NCT04204616
NCT06427122
NCT06213831
Lead Sponsor
Sanofi
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions